Bio-Works Technologies
Bio-Works receives a Letter of Intent (LOI) - the anticipated order value is €652,000.
REG
This LOI marks a pivotal step toward reinforcing Bio-Works' relationship with our customers in the biopharmaceutical industry. Bio-Works' WorkBeads affimAb product has shown exceptional value in high-stakes manufacturing environments, with data from multiple manufacturing sites affirming its performance.
"We are thrilled about the potential of this order, as it underscores the trust and value placed in Bio-Works' products by industry leaders" said Lone Carlbom, CEO of Bio-Works. "This LOI is a testament to our commitment to quality and innovation, and we look forward to further strengthening our partnerships across the biopharmaceutical sector."
| Datum | 2024-11-04, kl 08:37 |
| Källa | Cision |
Alla Aktier tipsar: Har du redan ett konto på Avanza? Varför inte skapa ett på Nordnet också och jämföra funktioner, courtage mm. Det tar inte lång tid, du fixar det direkt här med BankID
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet